|
HY-135932-50mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139385A-100mg
|
MedChemexpress LLC
|
mPEG-DSPE (MW 2000) (sodium)
|
|
Cancer-programmed cell death
|
|
|
HY-139385A-50mg
|
MedChemexpress LLC
|
mPEG-DSPE (MW 2000) (sodium)
|
|
Cancer-programmed cell death
|
|
|
HY-14609-10mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-5mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-50mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-1mL
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609A-250mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-10mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-100mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-5mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-50mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-1mL
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148516-10mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-100mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-25mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-5mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-50mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-103454-5mg
|
MedChemexpress LLC
|
MPP (dihydrochloride) [CAS 911295-24-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-W008719-100mg
|
MedChemexpress LLC
|
MPP+ (iodide) [CAS 36913-39-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-W008719-1mL
|
MedChemexpress LLC
|
MPP+ (iodide) [CAS 36913-39-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-W008719S-1mg
|
MedChemexpress LLC
|
MPP+-d3(iodide) [CAS 207556-07-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W008719S-10mg
|
MedChemexpress LLC
|
MPP+-d3(iodide) [CAS 207556-07-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W008719S-5mg
|
MedChemexpress LLC
|
MPP+-d3(iodide) [CAS 207556-07-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-132161-1mg
|
MedChemexpress LLC
|
MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT [CAS 2378428-19-2]
|
|
Cancer-programmed cell death
|
|
